
1. cns oncol. 2015;4(2):91-104. doi: 10.2217/cns.14.55.

treating recurrent glioblastoma: update.

kamiya-matsuoka c(1), gilbert mr.

author information: 
(1)department neuro-oncology, university texas md anderson cancer center,
houston, tx 77030, usa.

glioblastoma, aggressive gliomas, high recurrence and
mortality rate. nature poor prognosis resides molecular
heterogeneity phenotypic features tumor. despite research advances in
understanding molecular biology, difficult translate this
knowledge effective treatment. nearly tumor recurrence, yet to
date therapies established efficacy salvage regimens. this
challenge complicated imaging confounders even greater
degree ever increasing molecular heterogeneity thought 
sporadic treatment-induced. development novel clinical trial designs
to support development testing novel treatment regimens drug
delivery strategies underscore need precise techniques imaging
and better surrogate markers help determine treatment response. review
summarizes recent approaches treat patients recurrent glioblastoma and
considers future perspectives.

doi: 10.2217/cns.14.55 
pmcid: pmc6093021
pmid: 25768333  [indexed medline]

